Targeted delivery of doxorubicin: Drug delivery system based on PAMAM dendrimers

Biochemistry (Moscow)

Volumn 78, Issue 8, 2013, Pages 884-894

  Yabbarov, N G ^a   Posypanova, G A ^b   Vorontsov, E A ^c   Popova, O N ^b   Severin, E S ^c  

^a INSTITUTE OF BIOENGINEERING   (Russian Federation)

^b KURCHATOV INSTITUTE   (Russian Federation)

^c Russian Scientific Center of Molecular Diagnostics and Therapy   (Russian Federation)

Author keywords

acid labile linker; alpha fetoprotein; antitumor; dendrimers; endocytosis; targeted drug delivery

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DENDRIMER; DOXORUBICIN; DRUG CARRIER; PAMAM STARBURST;

ADENOCARCINOMA; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; METHODOLOGY; OVARY TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DENDRIMERS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 84882660641     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S000629791308004X     Document Type: Article

References (33)

1. Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; and Smith, P. (1985) Polymer J.; 17, 117-132.
2. Aulenta, F.; Hayes, W.; and Rannard, S. (2003) Eur. Polymer J.; 39, 1741-1771.
3. Svenson, S.; and Tomalia, D. A. (2005) Adv. Drug Deliv. Rev.; 57, 2106-2129.
4. Boas, U.; and Heegaard, P. M. H. (2004) Chem. Soc. Rev.; 33, 43-63.
5. Sampathkumar, S.-G.; and Yarema, K. J. (2007) in Nanotechnologies for the Life Sciences, Wiley-VCH Verlag GmbH & Co. KGaA.
6. Sinha, B. K.; and Politi, P. M. (1990) Cancer Chemother. Biol. Response Modif.; 11, 45-57.
7. Agarwal, A.; Saraf, S.; Asthana, A.; Gupta, U.; Gajbhiye, V.; and Jain, N. K. (2008) Int. J. Pharmac.; 350, 3-13.
8. Ward, B. B.; Dunham, T.; Majoros, I. J.; and Baker, J. R.; Jr. (2011) J. Oral Maxillofac. Surg.; 69, 2452-2459.
9. Chen, K.; and Mitchell, D. (2012) in Glioma (Yamanaka, R.; ed.) Springer, New York, Vol. 746, pp. 121-141.
10. Miyano, T.; Wijagkanalan, W.; Kawakami, S.; Yamashita, F.; and Hashida, M. (2010) Mol. Pharmac.; 7, 1318-1327.
11. Moro, R.; Tcherkassova, J.; and Song, E. (2005) IVD Technology [Online] Available at: http://www.ivdtechnology.com/article/new-broad-spectrum-cancer- marker.
12. Nitsvetov, M. B.; Moskaleva, E. Y.; Posypanova, G. A.; Makarova, O. V.; Stepanov, V. A.; Rogov, K. A.; Koromyslova, I. A.; Karaulov, A. V.; Severin, S. E.; and Severin, E. S. (2005) Immunologiya, 26, 122-125.
13. Moskaleva, E. Y.; Posypanova, G. A.; Koromyslova, I. A.; Shmyrev, I. I.; Krivonos, A. V.; Myagkikh, I. V.; Feldman, N. B.; Finakova, G. V.; Katukov, V. Y.; Luzhkov, Y. M.; Nakachian, R.; Andreani, J.; Severin, E. S.; and Severin, S. E. (1996) Tumor Target.; 2, 299-306.
14. Severin, S. E.; Posypanova, G. A.; Katukov, V. Y.; Shmyrev, I. I.; Luzhkov, Y. M.; Gerasimova, G. K.; Zhukova, O. S.; Vorozhtsov, G. N.; Kaliya, O. L.; Lukyanets, E. A.; and Severin, E. S. (1997) Biochem. Mol. Biol. Int.; 43, 1081-1089.
15. Posypanova, G. A.; Gorokhovets, N. V.; Makarov, V. A.; Savvateeva, L. V.; Kireeva, N. N.; Severin, S. E.; and Severin, E. S. (2008) J. Drug Target.; 16, 321-328.
16. Godovannyi, A. V.; Savvateeva, M. V.; Sotnichenko, A. I.; Yabbarov, N. S.; Klimova, O. V.; Gnuchev, H. V.; and Severin, S. E. (2011) Mol. Med.; 1, 44-48.
17. Sambrook, J.; and Russell, D. G. (2001) Molecular Cloning: A Laboratory Manual, 3rd Edn.; Cold Spring Harbor Laboratory Press, New York.
18. Sharapova, O. A.; Yurkova, M. S.; Laurinavichyute, D. K.; Andronova, S. M.; Fedorov, A. N.; Severin, S. E.; and Severin, E. S. (2011) J. Chromatogr. A, 1218, 5115-5119.
19. Perumal, O. P.; Inapagolla, R.; Kannan, S.; and Kannan, R. M. (2008) Biomaterials, 29, 3469-3476.
20. Butcher, E. C.; and Weissman, I. L. (1980) J. Immunol. Meth.; 37, 97-108.
21. Tian, Y.; Bromberg, L.; Lin, S. N.; Alan Hatton, T.; and Tam, K. C. (2007) J. Contr. Rel.; 121, 137-145.
22. Boyum, A. (1968) Scand. J. Clin. Lab. Invest.; 97(Suppl.), 77-89.
23. Denizot, F.; and Lang, R. (1986) J. Immunol. Meth.; 89, 271-277.
24. Torres, J. M.; Laborda, J.; Naval, J.; Darracq, N.; Calvo, M.; Mishal, Z.; and Uriel, J. (1989) Mol. Immunol.; 26, 851-857.
25. Kitchens, K. M.; Kolhatkar, R. B.; Swaan, P. W.; and Ghandehari, H. (2008) Mol. Pharm.; 5, 364-369.
26. Saovapakhiran, A.; D'Emanuele, A.; Attwood, D.; and Penny, J. (2009) Bioconj. Chem.; 20, 693-701.
27. Qi, R.; Mullen, D. G.; Baker, J. R.; and Banaszak Holl, M. M. (2009) Mol. Pharm.; 7, 267-279.
28. Kitchens, K. M.; Foraker, A. B.; Kolhatkar, R. B.; Swaan, P. W.; and Ghandehari, H. (2007) Pharm. Res.; 24, 2138-2145.
29. Seib, F. P.; Jones, A. T.; and Duncan, R. (2007) J. Contr. Rel.; 117, 291-300.
30. Albertazzi, L.; Serresi, M.; Albanese, A.; and Beltram, F. (2010) Mol. Pharm.; 7, 680-688.
31. Severin, S. E.; Posypanova, G. A.; Sotnichenko, A. I.; Moskaleva, E. Y.; Feldman, N. B.; Grigoriev, M. I.; Severin, E. S.; and Petrov, R. V. (1999) Dokl. Akad. Nauk SSSR, 366, 561-564.
32. Sharapova, O. A.; Posdnyakova, N. V.; Laurinavichyute, D. K.; Yurkova, M. S.; Posypanova, G. A.; Andronova, S. M.; Fedorov, A. N.; Severin, S. E.; and Severin, E. S. (2010) Bioorg. Khim.; 36, 760-768.
33. Esteban, C.; Trojan, J.; Macho, A.; Mishal, Z.; Lafarge-Frayssinet, C.; and Uriel, J. (1993) Leukemia, 7, 1807-1816.